Uflex Ltd Q1 FY2023 Concall Summary

Key Takeaways

• Highest ever PAT, aseptic shines: Aseptic packaging hit 91% utilization and turned in a "phenomenal" quarter, while the Nigeria plant reached EBITDA-positive territory.
• Price, not volume, drove the ~47% topline surge: Volume grew 16%, so substantive raw-material-led price increases did the heavy lifting on revenue.
• Russia FX hit the P&L, but the company won't say how much: The ruble's wild swing from 125 to 55 caused an unquantified loss on receivables; management explicitly declined to share the number.
• Debt is still climbing toward a March 2023 peak: Net debt rose ₹150 Crores, with ₹156 Crores of that from Russian currency appreciation alone; new project draws are being offset by current amortization, and debt is expected to peak by March 31, 2023.
• What to watch next quarter: Whether raw-material softening translates to margin retention or price givebacks, the pace of aseptic debottlenecking toward 900 crore packs, and any concrete IR improvements from the newly hired agency.

Aseptic Packaging: The Standout Performer

• Utilization surged to 91% after the new line commissioned in April, despite initial teething troubles that were subsequently overcome. The enhanced capacity arrived just in time for the season.
• Debottlenecking, not new investment: Management is optimizing the existing plant to reach 900 crore packs per year without fresh capital. The season is now off; work resumes in January, and things should be sorted out by then.
• Revenue and margin visibility: At 700 crore packs output, annualized revenue can hit ₹1,200–1,400 Crores, with a sustainable EBITDA margin of about 20%. A clearer picture on capacity additions beyond debottlenecking is promised by the end of next quarter.
• No separate listing planned: Despite being called a good idea on a prior call, management has given no consideration to listing the aseptic packaging business separately as of now.

Rajesh Bhatia: "we not looking at any fresh investment per se but we are looking to debottleneck the facility to see if we can still optimize the production from the same plant to 900 crore packs."

Russia, Currency & the Unquantified Hit

• Ruble volatility created a P&L loss: The ruble moved from 75 to 125 and back to 55, and because receivables are benchmarked to certain exchange rates, the swing caused underperformance. Management confirmed a P&L impact but declined to quantify it when pressed by an analyst.
• Currency also inflated debt: Russian currency appreciation caused rupee-term debt to rise by ₹156 Crores, a major component of the ₹150 Crore overall net debt increase this quarter.
• The opacity is a risk: An analyst asked directly for the one-off P&L impact and was told, "We will not be able to share that." Investors are left to guess at the scale of the damage.

Raw Materials: Early Signs of Softening, No Commitments

• A marginal, recent fall: Some softening was observed between 15 July and 15 August 2022, but the decline has been marginal and the time period very short. Management called it "too premature" to quantify or call a trend.
• Price hikes have been passed through constantly in the larger business area, though flexible packaging may carry a certain lag. If raw materials decline further, the company can either pass prices on or retain some margin, depending on demand-supply dynamics.
• Backward integration is the structural answer: The Panipat project addresses raw-material availability and erratic pricing. Consistent quality from a single source will also reduce quality fluctuations, and markups on Ind-As have "shot up quite a bit" in this space.

Rajesh Bhatia: "I think it is too premature. I think this trend has only been for a few days so let us not have had a guess on that when we have the next quarter I think we will give you that as to what happened to the prices."

BOPET & Global Film Dynamics

• Indian margin trends mislead on global reality: Management warned that Indian BOPET margin trends are not representative of global markets, where gross margins are moving in different directions. Demand recovery is expected in European, Middle Eastern, North African, and African markets for the balance of the year.
• Net capacity additions are concentrated: New BOPET supply is coming mainly in India and China; rest-of-world net additions are very limited and almost negligible. Companies with global market presence, like UFlex, can manage the trade winds from these additions.
• R-PET adoption is patchy: Demand for 100% recycled-content film has not yet crystallized everywhere. Adoption varies by geography, driven by regulation or end-customer marketing. Where a consistent premium exists, it allows a better payback period for the material.

Apoorvshree Chaturvedi: "companies in position like ours where we have a complete understanding and representing Indian markets along with the global market leaders I think we will be able to manage the trade winds that developed out of the net capacity addition"

Specialty Films: A Definitional Dispute

• UFlex won't disclose the volume mix: Management declined to provide specialty sales as a percentage of total, arguing that its internal definition (based on volume and margin thresholds) is far stricter than the industry's inconsistent benchmarks. Disclosing the number would therefore be "futile."
• The rough benchmark is a 15% gross-margin expansion on specialty sales, but the company did not disclose what volume percentage clears that bar. An analyst asked for the internal threshold; management gave the margin benchmark but not the volume split.

Anantshree Chaturvedi: "I am sorry to spin this on you but that is exactly the problem right, the problem is our internal benchmarks so what we define specialty is very, very different from what the industry defines the specialty and that is the reason why we do not sort of reduce these numbers because a lot of times what is being called a specialty is not necessarily specialty..."

Capital Allocation: Growth Now, Shareholders Later

• Debt peaks March 2023: Debt did not increase this quarter despite draws for new CPP and BOPET facilities, because current amortization is offsetting new project debt. The expectation is that peak debt will be hit by March 31st, 2023, after which it starts coming down.
• Dividends take a back seat to growth: Absolute dividend payouts have increased, but the payout ratio has declined because significant capital is being spent on growth (aseptic, new facilities, backward integration) and lenders have guided on how much equity to plow back. Management will consider a higher payout ratio once growth opportunities are exhausted and idle cash is not kept.
• Dubai listing on hold: Markets are not conducive right now; the company will resume when markets return. The investment bankers' roadmap shows the listing putting the company UFlex parent valuation "in a completely different perspective." No dilution details were disclosed.
• No promoter buyback: There is no plan for any large-scale buyback structure; capital requirements are currently elsewhere.

Rajesh Bhatia: "we are a progressive company and wherever we see that we can generate a much better returns rather than sort of giving it in the form of dividend if there are opportunities reasonable opportunities for growth I think we have been pursuing that and once we stop pursuing that then yes of course you do not keep the ideal cash with yourself so there will be distributions for sure."

Guidance & Commitments

Key Metrics